M&A operations and value creation in the pharma industry (1999-2019): the case study of bristol myers Squibb-Celgene

Santi, Alida (A.A. 2018/2019) M&A operations and value creation in the pharma industry (1999-2019): the case study of bristol myers Squibb-Celgene. Tesi di Laurea in Business valuation, Luiss Guido Carli, relatore Alfio Torrisi, pp. 223. [Master's Degree Thesis]

[img] PDF (Full text)
Restricted to Registered users only

Download (10MB) | Request a copy

Abstract/Index

The pharma business in the world. Global pharmaceutical manufacturing industry evolution. How to create value in M&A. Creating value with mergers & acquisitions: the Hazelkorn-Zenner model. Bristol myers Squibb-Celgene M&A. BMS-Celgene M&A analysis with the model of Hazelkorn-Zenner.

References

Bibliografia: pp. 101-107.

Thesis Type: Master's Degree Thesis
Institution: Luiss Guido Carli
Degree Program: Master's Degree Programs > Master's Degree program in Corporate Finance, English language (LM-77)
Chair: Business valuation
Thesis Supervisor: Torrisi, Alfio
Thesis Co-Supervisor: Santella, Rosella
Academic Year: 2018/2019
Session: Autumn
Deposited by: Alessandro Perfetti
Date Deposited: 17 Mar 2020 14:17
Last Modified: 17 Mar 2020 14:17
URI: https://tesi.luiss.it/id/eprint/25963

Downloads

Downloads per month over past year

Repository Staff Only

View Item View Item